Scientists restored tissue regeneration in mice by flipping an ancient genetic switch linked to retinoic acid, opening doors for regenerative medicine.
In a May 7, 2024 press release, Seragon Biosciences announced that its aging intervention drug candidate, SRN-901, achieved one of the largest extensions of